Nanocellulose has been reported to be a very useful biomaterial with applications in biomedical, pharmaceutical, built industry, automobile, aerospace and many more. Its advantages over synthetic fibers include renewability, energy efficiency, cost effectiveness, biodegradability and good mechanical and thermal properties. However, the production of cellulose nanoparticles (CNPs) has focused more on woody plant sources. Non-woody biomass constitutes a large group of plant sources that are yet to be given the proper attention for utilization as raw material for nanocellulose particle production. This group of lignocellulosic biomasses is generally obtained as waste from farming activities, home gardens or office wastes. They are majorly composed of cellulose, hemicellulose, and lignin. However, their composition varies widely from one plant source to another. The variation in their composition results in limitations in the procedures employed in extraction of CNPs and of processing of the extracted CNPs. This means that different biomasses may have different ways by which CNPs are extracted from them. Therefore, this review intends to x-ray these variations, its effect on the structural properties of extracted CNPs and possible ways such limitations can be mitigated.
Fiber-matrix interaction at the interphase is one very important property that is of great concern to all polymer scientists involved in polymer composites. Many of the failures can be traced to the type of interfacial interaction existing in the composites. That is why highlighting the factors that dictate the type of and the extent of interactions at the interphases become very necessary. Natural fiber polymer composites have found application in many fields of human endeavors. To continue this growth being experienced, the factors that determine the formation of good interaction at the interphase most be understood, so that they can be manipulated for a better result.
Natural fiber composites are designed for different purposes including structural and non-structural ones. These natural fiber composites vary greatly in their properties including mechanical properties. Mechanical properties which include the tensile and flexural properties are highly dependent on factors such as matrix type, filler type, processing, post processing treatment and many more, factors which are quite application specific. However, many research works develop their natural fiber composite before considering the possible applications. This chapter intends to X-ray the factors that affect the mechanical properties as it relates to structural and biomedical applications and suggest ways of improving the mechanical properties.
3 March 2021 in International Journal of Environmental Science and Technology
Obesity is the accumulation of excess body fat and the hallmark of type II diabetes mellitus, characterized by hyperglycemia. Glycemic control is very critical to reduce long-term vascular complications resulting from the progressive nature of hyperglycemia. In previous studies, thermally reduced graphene oxide (rGO)-based hydrogel biocomposites were prepared and in vitro drug release studies confirmed their potential as a biodegradable-targeted drug delivery system. Thus, the in vitro biological evaluation of these rGO-based hydrogels was investigated. The hydrogels were encapsulated with chloroquine diphosphate (CQ) and proguanil (P) drugs to investigate potential of combination therapy. The non-toxic nature of the hydrogels was investigated by the use of the MTT assay against 3T3-L1 and c2c12 cell lines. 3T3-L1 pre-adipocytes were grown, differentiated and treated with the drug-encapsulated hydrogels to detect the effect on the adipose tissue cells by quantitative real-time polymerase chain reaction (qPCR) identifying gene expression levels by utilizing gene markers specific for diabetes and obesity: cpt-1, glut-4, acc1, pgc-1, mef2a and nrf-1 with comparison to positive control metformin. The cytoxicity studies confirmed non-toxic nature of the hydrogels; identified dosage of drugs encapsulated were effective within investigated treatment time and qPCR revealed an upregulation of CPT-1, GLUT-4, PGC-1, MEF2A and NRF-1 marker genes, but a downregulation of ACC-1 marker gene. The results from the expression of investigated genes suggest the anti-obesity potential of drugs released from the hydrogels. There were identified positive effects employing combination therapy, but further studies are required to ascertain the actual effect of the drugs in combination, by further varying the ratios of drugs (instead of the presented 1:1 ratio) employed. Statistically, the results from the individual drug release treatments were not significantly different from positive control metformin treatments, but the combination therapy investigation showed more promise.